Unapproved stem-cell treatments touted on federal database ClinicalTrials.gov, study says
Stem cell clinics offering unapproved treatments for ailments from hip pains to autism to erectile dysfunction increasingly are using a federal clinical-trials database as a marketing tool — a strategy that confuses patients and exposes them to “unjustifiable” safety risks and high costs, according to a new study. At least 18 purported clinical trials — […]Related:‘How did this happen to a 10-year-old?’: Child dies with heroin and fentanyl in his systemWhy this adorable mouse is to blame for the spread of Lyme diseaseNew NIH report finds low morale, continued patient safety concerns
Source: Washington Post: To Your Health - Category: Consumer Health News Source Type: news
More News: Autism | Children | Clinical Trials | Databases & Libraries | Erectile Dysfunction | Fentanyl | Health | Lyme Disease | Marketing | Stem Cell Therapy | Stem Cells | Study